Image
Image

REGULAR NEWS ON INNOVATIVE ANTIBODIES AND FREE MARKET INFORMATION

What you'll find in our newsletters

  • Free e-books on market figures and future trends including cell therapy, immunotherapy, infectious diseases, small molecules,...
  • Learn tricks to drastically increase success rate in antibody generation
  • Discover unique practical tools for your applications : anti-VHH, anti-His Tag, guinea pig antibodies, immuno-affinity columns...
 

What if we talk about the results?

" We chose to launch one ‘hard’ program with SYnAbs in order to develop an anti-PTM antibody. Indeed, there is no existing available monoclonal antibody for that given modification as of today
 
We are delighted with the collaboration with SYnAbs! They know what they are talking about and have considerable experience with antibody production "

- Gaetan Michel, VolitionRx, CEO 
SYnAbs has done a tremendous job in customized generation of a monoclonal antibody thanks to their unique multi-species immunization approach.
 
They generated the first worldwide monoclonal antibody against our confidential peptide. They also demonstrated great flexibility working with is and dealing with logistic aspects between our respective countries "

- Tzvika Tzubery, Neurogenic Ltd, CSO 

SYnAbs© All rights reserved